Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a 12% survival rate. highlighting the need for novel therapies. c-MYC overexpression. driven by upstream mutations and amplifications. https://danddcollectiblers.shop/product-category/pu/